Contract development and manufacturing leaders at Advanced Therapies Week 2025 delivered a stark message: the traditional Contract Development and Manufacturing Organization (CDMO) model for cell and gene therapies must undergo radical transformation to survive. From market consolidation to artificial intelligence,
Sterile injectable CDMOs are Contract Development and Manufacturing Organizations that provide services for the production of sterile injectable drugs. The sterile injectables contract development and manufacturing organization (CDMO) sector is experiencing unprecedented transformation, driven by soaring demand for breakthrough therapies
CDMOs vs CROs vs CMOs: This infographic highlights key outsourcing services at each stage of Drug Development and expert advice
Microbial fermentation is one of the most versatile and transformative technologies in both the pharmaceutical and food industries. Within the biopharmaceutical sector, this technology has revolutionized the production of therapeutics, playing a crucial role in manufacturing everything from basic proteins
Manufacturing strategy has become a critical differentiator in biotech funding rounds, directly impacting company valuation and exit opportunities. This guide helps biotech leaders prepare for investor scrutiny of their manufacturing approach, ensuring your strategy demonstrates both operational maturity and commercial
Oral Solid Dosage (OSD) drug formulations account for 84 percent of medications on the market, largely due to their stability and ease of administration for patients. The well-established oral solid dosage contract manufacturing market is experiencing robust growth, driven by
This report summarises the key factors driving price changes at the end of the 2024, and into the new year: Biologics contract manufacturing The global biologics contract manufacturing (biopharma CMO) market is expected to record a CAGR of 10.3% over
Temperature-controlled packaging plays a crucial role in the biopharma industry. This guide, in partnership with Intelsius, explains all you need to know.
This report summarises the key issues impacting prices across a range of categories in the BioPharma industry in October-November 2024. Biologics contract manufacturing The BIOSECURE Act can lead to a supply shortage of biologic products, potentially driving prices upwards. The
Radiopharmaceuticals, a class of drugs that contain radioactive isotopes, are revolutionising the landscape of nuclear medicine, offering unprecedented opportunities for both diagnostic imaging and therapeutic applications. These sophisticated compounds are at the forefront of medical innovation, providing clinicians with powerful
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
